Crossmark Global Holdings’s Enanta Pharmaceuticals ENTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q1
Sell
-3,540
Closed -$219K 1304
2019
Q4
$219K Buy
+3,540
New +$219K 0.01% 1297
2018
Q4
Sell
-7,950
Closed -$679K 1440
2018
Q3
$679K Sell
7,950
-150
-2% -$12.8K 0.02% 773
2018
Q2
$939K Buy
8,100
+420
+5% +$48.7K 0.03% 620
2018
Q1
$621K Sell
7,680
-620
-7% -$50.1K 0.02% 797
2017
Q4
$487K Buy
8,300
+2,130
+35% +$125K 0.01% 1023
2017
Q3
$289K Buy
+6,170
New +$289K 0.01% 1341
2016
Q3
$289K Buy
+6,170
New +$289K 0.01% 1341